Cosmecca Korea

코스메카코리아 · 241710

Materials Chemicals · KOSDAQ

Small-cap

Market cap US$542.5M (₩748.7B)

Overview

Cosmecca Korea formulates and manufactures skincare and colour cosmetics, products such as moisturisers, foundations, and BB creams, on behalf of domestic and international beauty brands, handling everything from product development to finished goods.

It operates as an ODM and OEM partner (meaning it develops or manufactures products to a client brand's specification), supplying a broad range of global cosmetics companies. Listed on KOSDAQ, Korea's tech and small-cap board, the company runs production facilities in Korea, China, and the United States. Roughly two-fifths of its workforce is dedicated to research and development, underpinning an active intellectual-property registration programme.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$464.4M

▲ +22.2% YoY

Operating profit · FY2025

US$60.5M

▲ +38.4% YoY

Net income · FY2025

US$41.9M

▲ +7.7% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$341.1M(₩470.7B)	US$379.9M(₩524.3B)	US$464.4M(₩640.9B)
Operating profit	US$35.6M(₩49.2B)	US$43.7M(₩60.4B)	US$60.5M(₩83.5B)
Net income	US$24.6M(₩33.9B)	US$38.9M(₩53.7B)	US$41.9M(₩57.8B)

Revenue

FY2023US$341.1M
FY2024US$379.9M
FY2025US$464.4M

Operating profit

FY2023US$35.6M
FY2024US$43.7M
FY2025US$60.5M

Net income

FY2023US$24.6M
FY2024US$38.9M
FY2025US$41.9M

Key ratios (FY2025)

ROE

17.2%

Debt/Eq

87.9%

Op. margin

13.0%

Net margin

9.0%

Rev. YoY

▲ +22.2%

Why it matters

Cosmecca Korea acquired Englewood Lab, a New Jersey-based cosmetics manufacturer, giving it a direct US production base to serve North American brand clients.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?